pmc logo image
Pharmacokinetics and molecular detoxication.
J R Cashman, B Y Perotti, C E Berkman, and J Lin
Environ Health Perspect. 1996 March; 104(Suppl 1): 23–40.
PMCID: PMC1469571
 Is Cited by the Following Articles in this Archive:
Modifications of human carboxylesterase for improved prodrug activation
M. Jason Hatfield, Monika Wierdl, Randy M. Wadkins, and Philip M. Potter
Expert Opin Drug Metab Toxicol. Author manuscript; available in PMC 2009 September 1.
PMCID: PMC2556898
Published in final edited form as: Expert Opin Drug Metab Toxicol. 2008 September; 4(9): 1153–1165. doi: 10.1517/17425255.4.9.1153.
Manuscript: | Abstract | Full Text | PDF–754K |
Analysis of the Inhibition of Mammalian Carboxylesterases by Novel Fluorobenzoins and Fluorobenzils
Latorya D. Hicks, Janice L Hyatt, Teri Moak, Carol C. Edwards, Lyudmila Tsurkan, Monika Wierdl, Antonio Ferreira, Randy M. Wadkins, and Philip M. Potter
Bioorg Med Chem. Author manuscript; available in PMC 2008 June 1.
PMCID: PMC1995442
Published in final edited form as: Bioorg Med Chem. 2007 June 1; 15(11): 3801–3817. Published online 2007 March 12. doi: 10.1016/j.bmc.2007.03.012.
Manuscript: | Abstract | Full Text | PDF–1.8M |
Analysis of Mammalian Carboxylesterase Inhibition by Trifluoromethylketone-Containing Compounds
Randy M. Wadkins, Janice L. Hyatt, Carol C. Edwards, Lyudmila Tsurkan, Matthew R. Redinbo, Craig E. Wheelock, Paul D. Jones, Bruce D. Hammock, and Philip M. Potter
Mol Pharmacol. Author manuscript; available in PMC 2007 October 22.
PMCID: PMC2040115
Published in final edited form as: Mol Pharmacol. 2007 March; 71(3): 713–723. Published online 2006 December 13. doi: 10.1124/mol.105.021683.
Manuscript: | Abstract | Full Text | PDF–623K |
Modulation of P450-dependent ifosfamide pharmacokinetics: a better understanding of drug activation in vivo.
E. G. Brain, L. J. Yu, K. Gustafsson, P. Drewes, and D. J. Waxman
Br J Cancer. 1998 June; 77(11): 1768–1776.
PMCID: PMC2150313